Title |
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2003
|
DOI | 10.1002/14651858.cd003679.pub2 |
Pubmed ID | |
Authors |
R M Oates-Whitehead, A D'Angelo, B Mol |
Abstract |
The reported overall risk of deep venous thrombosis in gynaecological surgery ranges from 7 to 45%. Fatal pulmonary embolism is estimated to occur in nearly 1% of these women. Pharmaceutical interventions are one possible prophylactic measure for preventing emboli in women undergoing major gynaecological surgery. Agents include unfractionated heparin (low -dose and adjusted-dose), low-molecular-weight heparins, heparinoids and warfarin. |
Mendeley readers
The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 33 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 18% |
Student > Master | 4 | 12% |
Student > Doctoral Student | 3 | 9% |
Student > Bachelor | 3 | 9% |
Professor | 3 | 9% |
Other | 7 | 21% |
Unknown | 8 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 50% |
Nursing and Health Professions | 3 | 9% |
Agricultural and Biological Sciences | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Linguistics | 1 | 3% |
Other | 2 | 6% |
Unknown | 8 | 24% |